Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort

BACKGROUND: Atazanavir (ATV) not boosted by ritonavir (uATV) has been frequently used in the past for switching combination antiretroviral therapy (cART). However, the clinical outcomes and predictors of such strategy are unknown. METHODS: An observational study was carried out on the Italian MASTER...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Infect Dis
Egile Nagusiak: Postorino, Maria Concetta, Prosperi, Mattia, Focà, Emanuele, Quiros-Roldan, Eugenia, Di Filippo, Elisa, Maggiolo, Franco, Borghetti, Alberto, Ladisa, Nicoletta, Di Pietro, Massimo, Gori, Andrea, Sighinolfi, Laura, Pan, Angelo, Mazzini, Nicola, Torti, Carlo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5353877/
https://ncbi.nlm.nih.gov/pubmed/28298195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2322-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak